Riehl, J <br/><br/>
Chronic oral administration of CG-3703, a thyrotropin releasing hormone analog, increases wake and decreases cataplexy in canine narcolepsy.  [electronic resource] 

 -  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology  Jul 2000 
 - 34-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0893-133X 
<br/><br/><label>Standard No.: </label>10.1016/S0893-133X(99)00159-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Proteins--drug effects<br/>Body Weight--drug effects<br/>Catalepsy--drug therapy<br/>Dogs<br/>Female<br/>Male<br/>Narcolepsy--drug therapy<br/>Sleep Stages--drug effects<br/>Thyrotropin-Releasing Hormone--analogs & derivatives<br/>Thyroxine--blood<br/>Triiodothyronine--blood<br/>Wakefulness--drug effects